(millions of dollars) |
Cash Flows from Operating Activities |
Net income including noncontrolling interests |
42,206 |
31,398 |
19,658 |
46,867 |
41,615 |
Adjustments for noncash transactions |
|
|
|
|
|
Depreciation and depletion |
15,583 |
14,760 |
11,917 |
12,379 |
12,250 |
Deferred income tax charges/(credits) |
142 |
(1,135) |
– |
1,399 |
124 |
Postretirement benefits expense in excess of/
(less than) net payments |
544 |
1,700 |
(1,722) |
57 |
(1,314) |
Other long-term obligation provisions in excess of/
(less than) payments |
(151) |
160 |
731 |
(63) |
1,065 |
Dividends received greater than/(less than)
equity in current earnings of equity companies |
(273) |
(596) |
(483) |
921 |
(714) |
Changes in operational working capital, excluding cash and debt |
|
|
|
|
|
Reduction/(increase) – Notes and accounts receivable |
(7,906) |
(5,863) |
(3,170) |
8,641 |
(5,441) |
– Inventories |
(2,208) |
(1,148) |
459 |
(1,285) |
72 |
– Other current assets |
222 |
913 |
132 |
(509) |
280 |
Increase/(reduction) – Accounts and other payables |
8,880 |
9,943 |
1,420 |
(5,415) |
6,228 |
Net (gain) on asset sales |
(2,842) |
(1,401) |
(488) |
(3,757) |
(2,217) |
All other items – net |
1,148 |
(318) |
(16) |
490 |
54 |
Net cash provided by operating activities |
55,345 |
48,413 |
28,438 |
59,725 |
52,002 |
Cash Flows from Investing Activities |
Additions to property, plant and equipment |
(30,975) |
(26,871) |
(22,491) |
(19,318) |
(15,387) |
Proceeds associated with sales of subsidiaries, property, plant
and equipment, and sales and returns of investments |
11,133 |
3,261 |
1,545 |
5,985 |
4,204 |
Decrease/(increase) in restricted cash and cash equivalents |
224 |
(628) |
– |
– |
4,604 |
Additional investments and advances |
(3,586) |
(1,239) |
(2,752) |
(2,495) |
(3,038) |
Collection of advances |
1,119 |
1,133 |
724 |
574 |
391 |
Additions to marketable securities |
(1,754) |
(15) |
(16) |
(2,113) |
(646) |
Sales of marketable securities |
1,674 |
155 |
571 |
1,868 |
144 |
Net cash used in investing activities |
(22,165) |
(24,204) |
(22,419) |
(15,499) |
(9,728) |
Cash Flows from Financing Activities |
Additions to long-term debt |
702 |
1,143 |
225 |
79 |
592 |
Reductions in long-term debt |
(266) |
(6,224) |
(68) |
(192) |
(209) |
Additions to short-term debt |
1,063 |
598 |
1,336 |
1,067 |
1,211 |
Reductions in short-term debt |
(1,103) |
(2,436) |
(1,575) |
(1,624) |
(809) |
Additions/(reductions) in debt with three months or less maturity |
1,561 |
709 |
(71) |
143 |
(187) |
Cash dividends to ExxonMobil shareholders |
(9,020) |
(8,498) |
(8,023) |
(8,058) |
(7,621) |
Cash dividends to noncontrolling interests |
(306) |
(281) |
(280) |
(375) |
(289) |
Changes in noncontrolling interests |
(16) |
(7) |
(113) |
(419) |
(659) |
Tax benefits related to stock-based awards |
260 |
122 |
237 |
333 |
369 |
Common stock acquired |
(22,055) |
(13,093) |
(19,703) |
(35,734) |
(31,822) |
Common stock sold |
924 |
1,043 |
752 |
753 |
1,079 |
Net cash used in financing activities |
(28,256) |
(26,924) |
(27,283) |
(44,027) |
(38,345) |
Effects of exchange rate changes on cash |
(85) |
(153) |
520 |
(2,743) |
1,808 |
Increase/(decrease) in cash and cash equivalents |
4,839 |
(2,868) |
(20,744) |
(2,544) |
5,737 |
Cash and cash equivalents at beginning of year |
7,825 |
10,693 |
31,437 |
33,981 |
28,244 |
Cash and cash equivalents at end of year |
12,664 |
7,825 |
10,693 |
31,437 |
33,981 |